BHM® COVID-19 TESTS SUCCESSFULLY REGISTERED WITH THE MHRA

In Vitro Diagnostic TestingUnited Kingdom
Written By Guest User

Birmingham Biotech has registered two COVID-19 antigen lateral flow tests and a real-time reverse transcription polymerase chain reaction (rRT -PCR) test specially targeting at ORF1ab and N genes of SARS-CoV-2. 

Guest User
Previous

PARTNERSHIP WITH CHUNG MEI PHARMACEUTICAL FOR TAIWANESE PRODUCT DISTRIBUTION
Next

MOBILE HOSPITAL IN INDONESIA